WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Stock Ownership - Who owns Bioxcel Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bioxcel Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Vimal MehtaCEO and President2024-12-16983$0.36
$357.81Sell
Vimal MehtaCEO and President2024-12-162,134$0.36
$772.51Sell
Vincent OneillExecutive Vice President Chief of Product Development and Medical Officer2024-12-16165$0.35
$58.08Sell
Javier RodriguezChief Legal Officer Senior Vice President and Corporate Secretary2024-12-16210$0.36
$74.55Sell
Javier RodriguezChief Legal Officer Senior Vice President and Corporate Secretary2024-12-16220$0.36
$78.54Sell
Richard I. SteinhartChief Financial Officer2024-12-16205$0.36
$73.80Sell
Richard I. SteinhartChief Financial Officer2024-12-16372$0.36
$133.18Sell
Frank YoccaChief Scientific Officer2024-12-16205$0.36
$72.77Sell
Frank YoccaChief Scientific Officer2024-12-16225$0.35
$78.98Sell

1 of 1

BTAI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BTAI insiders and whales buy or sell their stock.

BTAI Shareholders

What type of owners hold Bioxcel Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vimal Mehta80.45%17,594,461$32.90MInsider
Bioxcel Holdings Inc80.33%17,566,750$32.85MInsider
Krishnan Nandabalan78.17%17,094,500$31.97MInsider
Rashmi Agarwal39.12%8,554,945$16.00MInsider
Vipin Agarwal39.12%8,554,945$16.00MInsider
Tarun K. Gupta39.10%8,550,396$15.99MInsider
Indu R. Gupta39.10%8,550,396$15.99MInsider
Suganthi Balasubramanian39.09%8,547,750$15.98MInsider
Diwakar Jain39.08%8,547,300$15.98MInsider
Anita Jain39.08%8,547,300$15.98MInsider

1 of 3

BTAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTAI1.18%98.82%Net Selling
PDSB11.47%24.13%Net Buying
JUNS3.95%32.80%Net Buying
MAIA6.41%14.09%Net BuyingNet Buying
CVM4.07%95.93%Net BuyingNet Buying
View Top Biotech Stocks

Bioxcel Therapeutics Stock Ownership FAQ

Who owns Bioxcel Therapeutics?

Bioxcel Therapeutics (NASDAQ: BTAI) is owned by 10.78% institutional shareholders, 905.16% Bioxcel Therapeutics insiders, and 0.00% retail investors. Vimal Mehta is the largest individual Bioxcel Therapeutics shareholder, owning 17.59M shares representing 80.45% of the company. Vimal Mehta's Bioxcel Therapeutics shares are currently valued at $33.61M.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.